Results 141 to 150 of about 15,981,489 (330)

Crohn Disease: Epidemiology, Diagnosis, and Management

open access: yesMayo Clinic proceedings, 2017
J. Feuerstein, A. Cheifetz
semanticscholar   +1 more source

Medical treatment of perianal crohn disease

open access: yesThe Saudi Journal of Gastroenterology, 2002
Crohn disease is a chronic illness that affects the gastrointestinal tract from the mouth to the anus. Perianal Crohn develops in 31-94% of patients over the course of their illness. It affects the skin in the perianal area, the anal canal and can
Al-Ghamdi Abdullah
doaj  

Nutritional and environmental determinants of maturation and disruption of the early life gut microbiome: A narrative review

open access: yesJournal of Parenteral and Enteral Nutrition, EarlyView.
Abstract The first 1000 days of life represent a critical window for gut microbiome assembly, with lifelong implications for child growth, immune development, and disease risk. This review synthesizes evidence on maternal, perinatal, and especially nutritional factors that influence early‐life intestinal colonization and highlights the consequences of ...
Carly Burow   +4 more
wiley   +1 more source

Crohn’s disease in women

open access: yes, 2013
Ivana Plavšic,1 Tea Štimac,2 Goran Hauser31Health Center, County of Primorje-Gorski Kotar, Rijeka, Croatia; 2Department of Gynecology, 3Department of Gastroenterology, Clinical Hospital Center Rijeka, Rijeka, CroatiaAbstract: This article ...
Plavšić I   +2 more
core  

Dual biologic therapy in inflammatory bowel disease, a retrospective cohort study of vedolizumab and anti‐tumor necrosis factor alpha therapy in children

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Despite advances in pediatric inflammatory bowel disease (PIBD) with biologics, remission rates remain at 47%–60% with loss‐of‐response rates at 60%–68%. Evidence for efficacy of dual biologic therapy (DBT) with anti‐tumor necrosis factor alpha therapy (anti‐TNF‐α)‐ vedolizumab (VDZ) for children refractory to anti‐TNF‐α therapy is ...
Jonathan E. M. O'Donnell   +6 more
wiley   +1 more source

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

open access: yesNature, 2001
Yasunori Ogura   +16 more
semanticscholar   +1 more source

Enigmas of IL-12R1 Deficiency: Contemporary of Two Disease, Mendelian Susceptibility to Mycobacterial Disease and Crohn Disease

open access: yes, 2019
Enigmas of IL-12R1 Deficiency: Contemporary of Two Disease, Mendelian Susceptibility to Mycobacterial Disease and Crohn ...
Kotlarz, D.   +9 more
core  

Anaemia in patients diagnosed with paediatric‐onset inflammatory bowel disease: A Danish nationwide cohort study

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Anaemia impairs daily activities and quality of life in patients with paediatric‐onset inflammatory bowel disease (PIBD). This study aimed to investigate the prevalence of anaemia at PIBD‐diagnosis and the following 5 years. Furthermore, anaemia subtypes and the association between anaemia and disease activity were assessed over ...
Julie Rahbek Norup   +3 more
wiley   +1 more source

Profile of infliximab in the treatment of pediatric Crohn’s disease

open access: yesPediatric Health, Medicine and Therapeutics, 2015
Jaroslaw Kierkus,1 Edyta Szymanska,2 Grzegorz Oracz,1 Anna Wiernicka,1 Maciej Dadalski1 1Department of Gastroenterology, Hepatology, Feeding Disorders and Pediatrics, 2Department of Pediatrics, Nutrition and Metabolic Disorders, The Children’s ...
Kierus J   +4 more
doaj  

Home - About - Disclaimer - Privacy